| | | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
|---|
|
| juin 2020 - 56 Spécialités |
|
| | | IPro | IPat | CM | Ibuprofen Viatris | 20 | 2.37 | 11.80 | 10% | | Granulé effervescent: Ibuprofenum 600 mg | Viatris Pharma GmbH | ● B / LS / SG | FB | | G |  |
| | | IPro | IPat | CM | Ibuprofen Viatris 200 mg | 30 | 1.43 | 10.80 | 10% | | Comprimés filmés: Ibuprofenum 200 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Ibuprofen Viatris 400 mg | 20 | 1.56 | 10.95 | 10% | | Comprimés filmés: Ibuprofenum 400 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Ibuprofen Viatris 400 mg | 50 | 3.37 | 12.90 | 10% | | Comprimés filmés: Ibuprofenum 400 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Ibuprofen Viatris 600 mg | 20 | 2.16 | 11.60 | 10% | | Comprimés filmés: Ibuprofenum 600 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Ibuprofen Viatris 600 mg | 100 | 9.17 | 26.40 | 10% | | Comprimés filmés: Ibuprofenum 600 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | IPat | CM | Ibuprofen Viatris retard | 20 | 3.90 | 13.50 | 10% | | Comprimés filmés: Ibuprofenum 800 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | IPat | CM | Ibuprofen Viatris retard | 50 | 8.48 | 25.65 | 10% | | Comprimés filmés: Ibuprofenum 800 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | IPat | CM | Ibuprofen Viatris retard | 100 | 15.08 | 32.85 | 10% | | Comprimés filmés: Ibuprofenum 800 mg | Viatris Pharma GmbH | B / LS / SG | FB | | G | |
| L | | IPro | IPat | | Treprostinil OrPha 1
mg/ml | 10 ml | 1088.35 | 1200.05 | 10% | | Solution pour perfusion: Treprostinilum 1 mg/ml | OrPha Swiss GmbH | B / LS / SG | FB | | G | |
| L | | IPro | | | Treprostinil OrPha 2.5
mg/ml | 10 ml | 2225.56 | 2436.85 | 10% | | Solution pour perfusion: Treprostinilum 2.5 mg/ml | OrPha Swiss GmbH | B / LS / SG | FB | | G | |
| L | | IPro | | | Treprostinil OrPha 5
mg/ml | 10 ml | 4451.12 | 4857.30 | 10% | | Solution pour perfusion: Treprostinilum 5 mg/ml | OrPha Swiss GmbH | B / LS / SG | FB | | G | |
| L | | IPro | | | Treprostinil OrPha 10
mg/ml | 10 ml | 8902.24 | 9441.50 | 10% | | Solution pour perfusion: Treprostinilum 10 mg/ml | OrPha Swiss GmbH | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Co-Valsartan Spirig HC
80/12.5 mg | 28 | 8.93 | 26.15 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Co-Valsartan Spirig HC
80/12.5 mg | 98 | 28.85 | 47.90 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Co-Valsartan Spirig HC
160/12.5 mg | 28 | 10.59 | 28.00 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Co-Valsartan Spirig HC
160/12.5 mg | 98 | 37.04 | 56.85 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Co-Valsartan Spirig HC
160/25 mg | 28 | 10.59 | 28.00 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Co-Valsartan Spirig HC
160/25 mg | 98 | 37.04 | 56.85 | 10% | | Comprimés filmés: 2 Principes actifs | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Valsartan Spirig HC 80 mg | 28 | 8.09 | 25.25 | 10% | | Comprimés filmés: Valsartanum 80 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Valsartan Spirig HC 80 mg | 98 | 26.13 | 45.10 | 10% | | Comprimés filmés: Valsartanum 80 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Valsartan Spirig HC 160 mg | 28 | 9.73 | 27.05 | 10% | | Comprimés filmés: Valsartanum 160 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | | | Valsartan Spirig HC 160 mg | 98 | 34.37 | 54.20 | 10% | | Comprimés filmés: Valsartanum 160 mg | Spirig HealthCare AG | B / LS / SG | FB | | G | |
| | | IPro | IPat | CM | Torasemid Mylan 2,5 mg | 20 | | 10.20 | 10% | | Comprimés: Torasemidum 2.5 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | IPat | CM | Torasemid Mylan 2,5 mg | 100 | 3.93 | 13.50 | 10% | | Comprimés: Torasemidum 2.5 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Torasemid Mylan 5 mg | 20 | 1.38 | 10.75 | 10% | | Comprimés: Torasemidum 5 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Torasemid Mylan 5 mg | 100 | 6.10 | 15.85 | 10% | | Comprimés: Torasemidum 5 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Torasemid Mylan 10 mg | 20 | 2.04 | 11.45 | 10% | | Comprimés: Torasemidum 10 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Torasemid Mylan 10 mg | 100 | 10.22 | 27.55 | 10% | | Comprimés: Torasemidum 10 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Torasemid Mylan 200 mg | 20 | 11.09 | 28.40 | 10% | | Comprimés: Torasemidum 200 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | | CM | Torasemid Mylan 200 mg | 100 | 49.56 | 70.05 | 10% | | Comprimés: Torasemidum 200 mg | Mylan Pharma GmbH | B / LS / SG | FB | | G | |
| | | IPro | IPat | | Inhixa 2000 IE (20 mg) | 10 | 15.04 | 32.75 | 10% | | Solution injectable: Enoxaparinum Natricum 20 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| L | | IPro | IPat | | Inhixa 2000 IE (20 mg) | 50 | 75.21 | 98.20 | 10% | | Solution injectable: Enoxaparinum Natricum 20 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 4000 IE (40 mg) | 2 | 5.60 | 15.30 | 10% | | Solution injectable: Enoxaparinum Natricum 40 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 4000 IE (40 mg) | 10 | 28.14 | 47.00 | 10% | | Solution injectable: Enoxaparinum Natricum 40 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| L | | IPro | | | Inhixa 4000 IE (40 mg) | 50 | 140.69 | 169.40 | 10% | | Solution injectable: Enoxaparinum Natricum 40 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 6000 IE (60 mg) | 10 | 36.74 | 56.35 | 10% | | Solution injectable: Enoxaparinum Natricum 60 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 8000 IE (80 mg) | 10 | 52.47 | 73.50 | 10% | | Solution injectable: Enoxaparinum Natricum 80 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 10000 IE (100 mg) | 10 | 65.56 | 87.70 | 10% | | Solution injectable: Enoxaparinum Natricum 100 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 12000 IE (120 mg) | 10 | 72.36 | 95.10 | 10% | | Solution injectable: Enoxaparinum Natricum 120 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa 15000 IE (150 mg) | 10 | 88.52 | 112.70 | 10% | | Solution injectable: Enoxaparinum Natricum 150 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| | | IPro | | | Inhixa Multi 30000 IE
(300 mg) | | 16.59 | 34.45 | 10% | | Solution injectable: Enoxaparinum Natricum 300 mg | Viatris Pharma GmbH | B / LS | FB | | G | |
| L | | IPro | IPat | | NUBEQA 300 mg | 112 | 2930.21 | 3203.20 | 10% | | Comprimés filmés: Darolutamidum 300 mg | Bayer (Schweiz) AG | B / LS | FB | | G | |
| L | | IPro | IPat | | Baqsimi | | 41.80 | 61.90 | 10% | | poudre nasale: Glucagonum 3 mg | Future Health Pharma
GmbH | B / LS | FB | | G | |
| | | IPro | IPat | | Inhixa 2000 IE (20 mg) | 2 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 20 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 6000 IE (60 mg) | 2 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 60 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 6000 IE (60 mg) | 50 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 60 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 8000 IE (80 mg) | 2 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 80 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 8000 IE (80 mg) | 50 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 80 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 10000 IE (100 mg) | 2 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 100 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 10000 IE (100 mg) | 50 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 100 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 12000 IE (120 mg) | 2 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 120 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | | Inhixa 15000 IE (150 mg) | 2 | DDP | DDP | N.O. | | Solution injectable: Enoxaparinum Natricum 150 mg | Viatris Pharma GmbH | B | FB | | G | |
| | | IPro | | V/S | Berinert SC 2000 IU | / 0 UI | DDP | DDP | N.O. | | Lyophilisat et solvant: C1-esterasi Inhibitor Humanus 2000 UI | CSL Behring AG | B | FB | | G | |
| | | IPro | | | Eotriz 4 mg/5 ml | | DDP | DDP | N.O. | | Concentré pour perfusion: Acidum Zoledronicum 4mg / 5ml | SciClone
Pharmaceuticals
Switzerland GmbH | B | FB | | G | |
| | | IPro | IPat | | Valsartan Spirig HC 40 mg | 28 | DDP | DDP | N.O. | | Comprimés filmés: Valsartanum 40 mg | Spirig HealthCare AG | B | FB | | G | |
